Is Right-Sided Pleural Mesothelioma Worse than Left-Sided?
Pleural mesothelioma develops from the thin layer of tissue that covers the lungs and chest wall. Pleural mesothelioma may develop in…
Peritoneal Mesothelioma and Palliative CRS/HIPEC Surgery
Peritoneal mesothelioma is the second most common form of asbestos cancer. Peritoneal mesothelioma affects the membrane around the abdominal organs.…
Reviewing Twenty Years of Malignant Mesothelioma in American Women
A new study shows twenty years of national trends associated with an increase of mesothelioma deaths in American women. Inhalation…
Biomarkers | Genetics | Research | Treatments
New Advancements in Personalized Medicine for Mesothelioma
Genomics is a new branch of medicine that involves using a patient’s genetic information to create personalized treatment. New research…
Electronic Health Record Supports Malignant Pleural Mesothelioma Research
A new method of research is becoming more popular in the study of malignant pleural mesothelioma. Most doctors use an…
Second Treatment Course May Increase Mesothelioma Patient Survival
Oncologists report that a second treatment course may be a good option for some mesothelioma patients. Almost all mesothelioma patients…
Nanoparticles May Offer New Treatment for Peritoneal Mesothelioma
American scientists may have found a new way to fight mesothelioma and other cancers from the inside out by targeting…
Mesothelioma Patients Underrepresented in European National Cancer Data
Cancer patient surveys are important for improving healthcare practice and policy. A new study suggests mesothelioma patients may be underrepresented…
New Anti-Mesothelioma Antibody and Biomarker Discovered
Dr. Tsuji is working on discovering specific cancer antigens for malignant mesothelioma. A new study from the Gunma University of…
A Bright Future for Immune Checkpoint Inhibitors in Mesothelioma Treatment
A new report shows that immune checkpoint inhibitors can be a practical and rational therapeutic approach to treating mesothelioma patients.…